Panel Recommends Everolimus in Kidney Transplant

Courtesy MedPage Today Surgery  Mon, 12/07/2009 - 16:41

WASHINGTON (MedPage Today) -- An FDA advisory panel said the antirejection drug everolimus appears safe and effective for use in kidney transplant patients, but should be marketed with a risk mitigation plan.


 

More related items

Pain Patch Rejected for HIV Neuropathy
(MedPage Today) -- SILVER SPRING, Md. -- By a vote of 12-0, an FDA advisory panel said a capsaicin skin patch did not relieve neuropathic pain from HIV.

FDA Okays New Kidney Transplant Drug
WASHINGTON (MedPage Today) -- The FDA has approved belatacept (Nulojix) for use with other immunosuppressants in preventing organ rejection in kidney transplant patients.

Panel Endorses Novel COPD Drug
WASHINGTON (MedPage Today) -- An FDA advisory panel has voted 13-4 that a 75 mcg once-daily dose of indacaterol (Arcapta Neohaler), an investigational long-acting beta-adrenergic agonist is...

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com